Virios Therapeutics (VIRI) Misses Q2 EPS by 3c
Virios Therapeutics (NASDAQ: VIRI) reported Q2 EPS of ($0.08), $0.03 worse than the analyst estimate of ($0.05).
For earnings history and earnings-related data on Virios Therapeutics (VIRI) click here.
Virios Therapeutics (NASDAQ: VIRI) reported Q2 EPS of ($0.08), $0.03 worse than the analyst estimate of ($0.05).
For earnings history and earnings-related data on Virios Therapeutics (VIRI) click here.